Diabetes drug dapagliflozin may protect hearts after attack
NCT ID NCT05050500
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether the diabetes drug dapagliflozin can reduce inflammation and improve outcomes in people with type 2 diabetes who recently had a heart attack. Researchers gave 143 patients either dapagliflozin or standard care for 6 months. They measured heart complications like another heart attack, stroke, or death, as well as levels of inflammatory markers in the blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dapagliflozin (a diabetes drug that also helps the heart)
- What this could lead to
- If successful, this could show that adding dapagliflozin to standard care after a heart attack reduces inflammation and lowers the risk of further heart problems in people with type 2 diabetes.
- What could go wrong
- This is a small, single-center Phase 4 study with only 143 participants. Results may not apply to all patients, and the drug may not show a clear benefit over standard therapy alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mengmei Li
Qingdao, Shandong, 266042, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your DNA could determine which heart drug works best
- Emotional stress may be a hidden trigger for repeat heart attacks — a study investigates
- A digital coach for the heart: app aims to keep risk factors in check after a heart attack
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers
- Could meal kits and text messages help curb diabetes in Food-Insecure communities?
- Could a sleep apnea machine keep heart patients out of the hospital?